scholarly journals Profound Bias in Interferon‐γ and Interleukin‐6 Allele Frequencies in Western Kenya, Where Severe Malarial Anemia Is Common in Children

2002 ◽  
Vol 186 (7) ◽  
pp. 1007-1012 ◽  
Author(s):  
Ian S. Gourley ◽  
Jonathan D. Kurtis ◽  
Malek Kamoun ◽  
Joseph J. Amon ◽  
Patrick E. Duffy
2007 ◽  
Vol 77 (6_Suppl) ◽  
pp. 23-28 ◽  
Author(s):  
Charles O. Obonyo ◽  
John Vulule ◽  
Willis S. Akhwale ◽  
Diederick E. Grobbee

2003 ◽  
Vol 10 (3) ◽  
pp. 362-366 ◽  
Author(s):  
Sujittra Chaisavaneeyakorn ◽  
Caroline Othoro ◽  
Ya Ping Shi ◽  
Juliana Otieno ◽  
Sansanee C. Chaiyaroj ◽  
...  

ABSTRACT In this study, we investigated whether levels of interleukin-12 (IL-12) and IL-18 in plasma are associated with severe malarial anemia outcomes in an area of holoendemicity in western Kenya. We compared plasma IL-12 and IL-18 levels in six groups of children grouped into the categories aparasitemic, asymptomatic, mild malaria, high-density uncomplicated malaria (UC), moderate malarial anemia (MMA), or severe malarial anemia (SMA). IL-12 levels were significantly reduced in children with SMA (P < 0.05) but not in other groups compared to children in the aparasitemic control group. IL-18, a cytokine known to be critical for the induction of gamma interferon along with IL-12, was produced more frequently (70%) in children with UC (P = 0.06) than in children in the aparasitemic control group (32%). However, in the SMA group the IL-18 response rate declined to 30%, which was similar to that in the aparasitemic control group, which showed a 32% response rate. This finding suggests that the IL-18 response may be impaired in children with SMA. In summary, the results from this study support the hypothesis that impairment of IL-12 and/or IL-18 response may contribute to the development of severe malarial anemia in areas of holoendemicity for malaria.


2009 ◽  
Vol 78 (1) ◽  
pp. 453-460 ◽  
Author(s):  
Collins Ouma ◽  
Christopher C. Keller ◽  
Gregory C. Davenport ◽  
Tom Were ◽  
Stephen Konah ◽  
...  

ABSTRACT Plasmodium falciparum malaria is a leading global cause of infectious disease burden. In areas in which P. falciparum transmission is holoendemic, such as western Kenya, severe malarial anemia (SMA) results in high rates of pediatric morbidity and mortality. Although the pathophysiological basis of SMA is multifactorial, we recently discovered that suppression of unexplored hematopoietic growth factors that promote erythroid and myeloid colony development, such as stem cell growth factor (SCGF) (C-type lectin domain family member 11A [CLEC11A]), was associated with enhanced development of SMA and reduced erythropoietic responses. To extend these investigations, the relationships between a novel SCGF promoter variant (−539C/T, rs7246355), SMA (hemoglobin [Hb] < 6.0 g/dl), and reduced erythropoietic responses (reticulocyte production index [RPI], <2.0) were investigated with Kenyan children (n = 486) with falciparum malaria from western Kenya. Circulating SCGF was positively correlated with hemoglobin levels (r = 0.251; P = 0.022) and the reticulocyte production index (RPI) (r = 0.268; P = 0.025). Children with SMA also had lower SCGF levels than those in the non-SMA group (P = 0.005). Multivariate logistic regression analyses controlling for covariates demonstrated that individuals with the homologous T allele were protected against SMA (odds ratio, 0.57; 95% confidence interval [95% CI] 0.34 to 0.94; P = 0.027) relative to CC (wild-type) carriers. Carriers of the TT genotype also had higher SCGF levels in circulation (P = 0.018) and in peripheral blood mononuclear cell culture supernatants (P = 0.041), as well as an elevated RPI (P = 0.005) relative to individuals with the CC genotype. The results presented here demonstrate that homozygous T at −539 in the SCGF promoter is associated with elevated SCGF production, enhanced erythropoiesis, and protection against the development of SMA in children with falciparum malaria.


2018 ◽  
Vol 31 (3) ◽  
pp. 1-10
Author(s):  
Stacey Gondi ◽  
Collins Ouma ◽  
Harrysone Atieli ◽  
Walter Otieno

2009 ◽  
Vol 77 (9) ◽  
pp. 3864-3871 ◽  
Author(s):  
Christopher C. Keller ◽  
Collins Ouma ◽  
Yamo Ouma ◽  
Gordon A. Awandare ◽  
Gregory C. Davenport ◽  
...  

ABSTRACT In areas of holoendemic Plasmodium falciparum transmission, severe malarial anemia (SMA) is a leading cause of pediatric morbidity and mortality. Although many soluble mediators regulate erythropoiesis, it is unclear how these factors contribute to development of SMA. Investigation of novel genes dysregulated in response to malarial pigment (hemozoin [PfHz]) revealed that stem cell growth factor (SCGF; also called C-type lectin domain family member 11A [CLEC11A]), a hematopoietic growth factor important for development of erythroid and myeloid progenitors, was one of the most differentially expressed genes. Additional experiments with cultured peripheral blood mononuclear cells (PBMCs) demonstrated that PfHz decreased SCGF/CLEC11A transcriptional expression in a time-dependent manner. Circulating SCGF levels were then determined for Kenyan children (n = 90; aged 3 to 36 months) presenting at a rural hospital with various severities of malarial anemia. SCGF levels in circulation (P = 0.001) and in cultured PBMCs (P = 0.004) were suppressed in children with SMA. Circulating SCGF also correlated positively with hemoglobin levels (r = 0.241; P = 0.022) and the reticulocyte production index (RPI) (r = 0.280; P = 0.029). In addition, SCGF was decreased in children with reduced erythropoiesis (RPI of <2) (P < 0.001) and in children with elevated levels of naturally acquired monocytic PfHz (P = 0.019). Thus, phagocytosis of PfHz promotes a decrease in SCGF gene products, which may contribute to reduced erythropoiesis in children with SMA.


2003 ◽  
Vol 82 (6) ◽  
pp. 543-549
Author(s):  
Ahmed M. Bahar ◽  
Hashim W. Ghalib ◽  
Riyad A. Moosa ◽  
Zaki M. S. Zaki ◽  
Chet Thomas ◽  
...  

2017 ◽  
Vol 65 (1) ◽  
pp. e26745 ◽  
Author(s):  
Robert O. Opoka ◽  
Paul Bangirana ◽  
Richard Idro ◽  
Estela Shabani ◽  
Ruth Namazzi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document